Combination treatment with low-dose Niaspan and tissue plasminogen activator provides neuroprotection after embolic stroke in rats
- 1 October 2011
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 309 (1-2) , 96-101
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Toll‐like receptor 4 in CNS pathologiesJournal of Neurochemistry, 2010
- Niaspan treatment induces neuroprotection after strokeNeurobiology of Disease, 2010
- Atorvastatin Extends the Therapeutic Window for tPA to 6 h after the Onset of Embolic Stroke in RatsJournal of Cerebral Blood Flow & Metabolism, 2009
- Toll-like receptor signaling in endogenous neuroprotection and strokeNeuroscience, 2009
- Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusionJournal of Neuroimmunology, 2007
- Neuroprotective Mechanism of Taurine due to Up-regulating Calpastatin and Down-regulating Calpain and Caspase-3 during Focal Cerebral IschemiaCellular and Molecular Neurobiology, 2007
- Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficitsProceedings of the National Academy of Sciences, 2007
- High-Density Lipoprotein as a Therapeutic TargetJAMA, 2007
- The inflammatory response in strokeJournal of Neuroimmunology, 2007
- Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient miceBiochemical and Biophysical Research Communications, 2007